{"id":6458,"date":"2022-06-21T21:58:53","date_gmt":"2022-06-21T13:58:53","guid":{"rendered":"https:\/\/www.excelsiormedical.com.tw\/?p=6458"},"modified":"2023-01-09T17:46:31","modified_gmt":"2023-01-09T09:46:31","slug":"the-2022-annual-shareholders-meeting-approved-the-companys-list-of-newly-elected-directors-including-independent-directors","status":"publish","type":"post","link":"https:\/\/www.excelsiormedical.com.tw\/en\/investors\/the-2022-annual-shareholders-meeting-approved-the-companys-list-of-newly-elected-directors-including-independent-directors\/","title":{"rendered":"The 2022 Annual Shareholders’ Meeting approved the Company’s list of newly elected directors (including independent directors)."},"content":{"rendered":"

 <\/p>\n\n\n\n\n\n\n
SEQ_NO<\/td>\n\u00a02<\/td>\nDate of announcement<\/td>\n2022\/06\/21<\/td>\nTime of announcement<\/td>\n21:58:13<\/td>\n<\/tr>\n
Subject<\/td>\n\n
The 2022 Annual Shareholders' Meeting approved\r\nthe Company's list of newly elected directors\r\n(including independent directors).<\/pre>\n<\/td>\n<\/tr>\n
Date of events<\/td>\n2022\/06\/21<\/td>\nTo which item it meets<\/td>\nparagraph 6<\/td>\n<\/tr>\n
Statement<\/td>\n\n
1.Date of occurrence of the change:2022\/06\/21\r\n2.Elected or changed position (Please enter \r\n  institutional director, institutional supervisor,\r\n  independent director, natural-person director or\r\n  natural-person supervisor):\r\n  Institutional director,independent director,natural\r\n  -person director.\r\n3.Title and name of the previous position holder:\r\n  Institutional director:\r\n  Excelsior Group Holdings Co., Ltd. Representative:\r\n  Chen Tun-Ling\r\n  Excelsior Group Holdings Co., Ltd. Representative:\r\n  Chang Hsien-Cheng\r\n  Natural-person director:\r\n  Fu Hui-Tung\r\n  Fu Jo-Hsuan\r\n  Hsieh Yen-Sheng\r\n  Wang Ming-Ting\r\n  Independent director:\r\n  Chan Tzu-Sheng\r\n  Chang Wu-I\r\n  Kuo Yu-Chia\r\n4.Resume of the previous position holder:\r\n  Institutional director:\r\n  Excelsior Group Holdings Co., Ltd. Representative:\r\n  Chen Tun-Ling\u2014Director of the Company.\r\n  Excelsior Group Holdings Co., Ltd. Representative:\r\n  Chang Hsien-Cheng\u2014Director of the Company.\r\n  Natural-person director:\r\n  Fu Hui-Tung\u2014Director of the Company.\r\n  Fu Jo-Hsuan\u2014Director of the Company.\r\n  Hsieh Yen-Sheng\u2014Director of the Company.\r\n  Wang Ming-Ting \u2014Director of the Company.\r\n  Independent director:\r\n  Chan Tzu-Sheng\u2014Independent director of the Company.\r\n  Chang Wu-I\u2014Independent director of the Company.\r\n  Kuo Yu-Chia\u2014Independent director of the Company.\r\n5.Title and name of the new position holder:\r\n  Institutional director:\r\n  Excelsior Group Holdings Co., Ltd. Representative:\r\n  Chen Tun-Ling\r\n  Excelsior Group Holdings Co., Ltd. Representative:\r\n  Chang Hsien-Cheng\r\n  Natural-person director:\r\n  Fu Hui-Tung\r\n  Fu Jo-Hsuan\r\n  Hsieh Yen-Sheng\r\n  Chang Ming-Cheng\r\n  Independent director:\r\n  Chang Wu-I\r\n  Kuo Yu-Chia\r\n  Jhan Cian-Long\r\n6.Resume of the new position holder:\r\n  Institutional director:\r\n  Excelsior Group Holdings Co., Ltd. Representative:\r\n  Chen Tun-Ling\u2014Director of the Company.\r\n  Excelsior Group Holdings Co., Ltd. Representative:\r\n  Chang Hsien-Cheng\u2014Director of the Company.\r\n  Natural-person director:\r\n  Fu Hui-Tung\u2014Director of the Company.\r\n  Fu Jo-Hsuan\u2014Director of the Company.\r\n  Hsieh Yen-Sheng\u2014Director of the Company.\r\n  Chang Ming-Cheng\u2014CEO of the Company.\r\n  Independent director:\r\n  Chang Wu-I\u2014Director of the Company.\r\n  Kuo Yu-Chia\u2014Director of the Company.\r\n  Jhan Cian-Long\u2014Dean of Soochow University \r\n  Business School.\r\n7.Circumstances of change (Please enter \r\n  \u201cresignation\u201d, \u201cdismissal\u201d,\u201cterm expired\u201d,\r\n  \u201cdeath\u201d or \u201cnew appointment\u201d):term expired\r\n8.Reason for the change:\r\n  Term expired and full re-election.\r\n9.Number of shares held by the new position \r\n  holder when elected: \r\n  Institutional director:\r\n  Excelsior Group Holdings Co., Ltd.(14,914,833 \r\n  shares)\r\n  Representative:Chen Tun-Ling(546,500 shares)\r\n  Excelsior Group Holdings Co., Ltd.(14,914,833 \r\n  shares)\r\n  Representative:Chang Hsien-Cheng(15,000 shares)\r\n  Natural-person director:\r\n  Fu Hui-Tung(469,993 shares)\r\n  Fu Jo-Hsuan(100,000 shares)\r\n  Hsieh Yen-Sheng(641,200 shares)\r\n  Chang Ming-Cheng (155,036 shares)\r\n  Independent director:\r\n  Chang Wu-I(0 shares)\r\n  Kuo Yu-Chia(0 shares)\r\n  Jhan Cian-Long(0 shares)\r\n10.Original term (from __________ to __________):\r\n   From 2019\/06\/18 to 2022\/06\/17\r\n11.Effective date of the new appointment:2022\/06\/21\r\n12.Turnover rate of directors of the same term:N\/A.\r\n13.Turnover rate of independent directors of the same \r\n   term:N\/A.\r\n14.Turnover rate of supervisors of the same term:N\/A.\r\n15.Change in one-third or more of directors (Please \r\n   enter \u201cYes\u201d or \u201cNo\u201d):No.\r\n16.Any other matters that need to be specified:None.<\/pre>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":"
  SEQ_NO \u00a02 Date of announcement 2022\/06\/21 Time of announcement 21:58:13 Subject The 2022 Annual Shareholders’ Meeting approved the Company’s list of newly elected directors (including independent directors). Date of events 2022\/06\/21 To which item it meets paragraph 6 Statement 1.Date of occurrence of the change:2022\/06\/21 2.Elected or changed position (Please enter institutional director, institutional …<\/p>\n
  The 2022 Annual Shareholders’ Meeting approved the Company’s list of newly elected directors (including independent directors).<\/span> Read More »<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[72,102],"tags":[],"class_list":["post-6458","post","type-post","status-publish","format-standard","hentry","category-investors","category-material-information"],"_links":{"self":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts\/6458","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/comments?post=6458"}],"version-history":[{"count":6,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts\/6458\/revisions"}],"predecessor-version":[{"id":6470,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts\/6458\/revisions\/6470"}],"wp:attachment":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/media?parent=6458"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/categories?post=6458"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/tags?post=6458"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}